HIV Vaccines in the News

Date: Dec 27, 2006
Title: Recruiters seeking volunteers to help stop the spread of HIV, Pair visit bars to enlist participants for vaccine trial
Source: Seattle Post-Intelligencer
Summary: Jarred Lathrop and Patrick Carr visit Seattle bars not to drink or shoot pool. They are recruiting for an HIV vaccine trial.
Date: Dec 8, 2006
Title: HIV and Malaria Epidemics Intertwine in Africa
Source: National Public Radio (audio file)
Summary: Southern Africa has uncontrolled epidemics of two very different infections: HIV and malaria. Many people are infected with both maladies. Researchers studying the illnesses say that dual infection is fueling the spread of both diseases. Dr. Jim Kublin of the HIV/AIDS Network Coordination office is interviewed.
Date: Dec 8, 2006
Title: Dual Infection with HIV and Malaria Fuels the Spread of Both Diseases in Sub-Saharan Africa
Source: Science
Summary: Mounting evidence has revealed pathological interactions between HIV and malaria in dually infected patients, but the public health implications of the interplay have remained unclear.
Date: Nov 20, 2006
Title: UNAIDS and World Health Organization releases new AIDS Epidemic update
Source: UNAIDS
Summary: Available in English, French, Russian, Spanish and German. The annual AIDS epidemic update reports on the latest developments in the global AIDS epidemic. With maps and regional summaries, the 2006 edition provides the most recent estimates of the epidemic’s scope and human toll, explores new trends in the epidemic’s evolution.
Date: Nov 6, 2006
Title: Uganda launches HIV vaccine trials for babies
Source: Johns Hopkins University Gazette
Summary: Scientists at Makerere University in Kampala, Uganda, along with scientists from Johns Hopkins and other institutions worldwide, have begun the first clinical safety trial in Africa of a vaccine to prevent mother-to-child transmission of HIV through breastfeeding.
Date: Oct 11, 2006
Title: NIAID Announces New Campaign To Raise Awareness Of Preventive HIV Vaccine Research
Source: Webwire
Summary: Young Americans are Challenged to "Be The Generation" that Ends the AIDS Epidemic. The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the launch of the "Be The Generation" public awareness campaign, challenging young Americans to be the generation that ends AIDS through the discovery of a safe and effective preventive HIV vaccine.
Date: Oct 3, 2006
Title: Four Jamaicans in HIV vaccine trial
Source: Jamaica Gleaner
Summary: The Epidemiology Research and Training Unit (ERTU) in the Ministry of Health has, to date, enrolled four persons for the HIV vaccine trial.
Date: Jul 28, 2006
Title: Special Issue: HIV/AIDS—Latin America & Caribbean
Source: Science
Summary: This special issue of Science magazine features 17 articles that look at the shape of the HIV/AIDS epidemic in Latin America and the Caribbean, the overlapping forces that have driven the spread of HIV in the region and the different ways the countries are fighting back. Video presentation and photo essay included.
Date: Jun 20, 2006
Title: How Close is the AIDS vaccine?
Source: KUOW, Puget Sound Public Radio
Summary: KUOW's Marcy Sillman interviews HVTN's Dr. Larry Corey and Dr. Julie McElrath about HIV vaccine research.
Date: Dec 2, 2005
Title: Interview with Dr. Michael Keefer
Source: Gay Alliance
Summary: Gay Alliance interviews HVTN's Dr. Keefer and a vaccine volunteer from Rochester, New York about the Step Study.
Date: Dec 1, 2005
Title: A World without AIDS
Source: MSNBC/Newsweek
Summary: After more than two decades, researchers say they are getting closer to developing an effective HIV/AIDS vaccine. Dr. Larry Corey, principal investigator of the HIV Vaccine Trials Network, is interviewed.
Date: Nov 30, 2005
Title: A World without AIDS
Source: Newsweek
Summary: An interview with Dr. Larry Corey.
Date: Nov 1, 2005
Title: Med trials get attention
Source: Emory Wheel
Summary: Paula Frew, director of communications and community education at the Hope Clinic, said about four trials are currently being conducted at the clinic, which primarily deals with the prevention of HIV. Some participants may be drawn from the Emory student body she said, but most are from the larger community.
Date: Oct 22, 2005
Title: HIV vaccine results are promising
Source: Seattle Times
Summary: An experimental HIV vaccine, which scientists say is the most promising in 20 years, has had such good results recently that researchers are doubling the number of volunteers involved in the trials. Scientists in Seattle and other cities in the international HIV Vaccine Trials Network have found much stronger immune responses than earlier tests showed.
Date: Oct 11, 2005
Title: NIAID Launches First Phase II Trial of a "Global" HIV/AIDS Vaccine
Source: NIH News
Summary: A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing. The study investigators plan to enroll a total of 480 participants at sites in Africa, North America, South America and the Caribbean to test the safety and immune response to the vaccine.
Date: Sep 23, 2005
Title: Enrollment to double in AIDS vaccine trialg
Source: Kaiser Network
Summary: Researchers conducting clinical trials of an AIDS vaccine made by pharmaceutical company Merck said they plan to double enrollment in the trials to 3,000 participants because results have exceeded their expectations.
Date: Aug 12, 2005
Title: Hedged Bet: An Unusual AIDS Vaccine Trial
Source: Science
Summary: Merck has constructed a vaccine that abandons antibodies altogether, and the company is testing it in the fast-tracked, Phase 2b Step Study.
Date: Aug 8, 2005
Title: Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research
Source: NIH News
Summary: A survey of 3500 U.S. adults finds that a majority are reluctant to support a friend or family member’s participation in an HIV vaccine clinical trial. The survey uncovered some unexpected attitudes and beliefs.
Date: June 28, 2005
Title: Investigational HIV/AIDS vaccine shows promise
Source: News 8 Austin
Summary: The HIV Vaccine Trials Network and Merck & Co., Inc. recently began the second phase of a study using an investigational HIV/AIDS vaccine. Dr. Julie McElrath, the lead scientist in the Seattle arm of the trial, says, "The only way to stop the epidemic is to develop and to implement a safe vaccine. We need it now; we need it yesterday."
Date: June 26, 2005
Title: Black volunteers line up to help find HIV vaccine
Source: The Birmingham News
Summary: The HVTN's Alabama Vaccine Research Clinic in Birmingham is successful in recruiting African-American volunteers into its HIV vaccine trials. Last year half of their participants were black.
Date: June 24, 2005
Title: Experts Say a Global Coordinated Research Effort is Needed for AIDS Vaccine
Source: Voice of America
Summary: HIV/AIDS researchers say they are optimistic that they will develop a vaccine for the deadly disease, although they say it will take at least another ten years.
Date: April 28, 2005
Title: HIV immunity insights aid vaccine research
Source: MyDNA
Summary: New insights by Duke University Medical Center researchers as to how HIV evades the human immune system may offer a new approach for developing HIV vaccines. The findings suggest some HIV vaccines may have failed because they induce a class of antibodies that a patient's own immune system is programmed to destroy.
Date: March 1, 2005
Title: Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Source: The Journal of Infectious Diseases
Summary: The "VAX004" study led by VaxGen, a California biopharmaceutical company, was a double-blind, randomized trial of a recombinant HIV-1 envelope glycoprotein subunit vaccine. A total of 5403 volunteers (5095 men and 308 women) were evaluated. There was no overall protective effect. The efficacy trends in subgroups may provide clues for the development of effective immunization approaches.
Date: January 28, 2005
Title: Novel AIDS Vaccine Trial
Source: Science
Summary: HVTN and Merck's AIDS vaccine study in seven countries aims to reduce the time needed to gauge its merit.
Date: January 25, 2005
Title: Merck begins human trials for vaccine to slow Aids
Source: Financial Times
Summary: Merck is beginning critical human trials for a vaccine that could prevent or decelerate HIV/Aids infections. Merck said it has begun enrolling an expected 1,500 volunteers globally to test the vaccine in people with a high risk of contracting HIV. The study is in collaboration with the HIV Vaccine Trials Network.
Date: January 25, 2005
Title: Seattle scientists expand testing of AIDS vaccine
Source: Seattle Post-Intelligencer
Summary: Seattle scientists plan to launch an innovative, international study of an experimental AIDS vaccine that has shown promise in earlier tests. "We're getting high levels of immune response," said Dr. Larry Corey, head of the HIV Vaccine Trials Network.
Date: January 24, 2005
Title: HIV vaccine is best hope in 20 years
Source: Seattle Times
Summary: An international effort coordinated by Seattle scientists will soon begin testing the most promising AIDS vaccine in more than 20 years of research.
Date: January 18, 2005
Title: The Global HIV Vaccine Enterprise
Source: Public Library of Science (PLOS)
Summary: In June 2003, an international group of scientists proposed the creation of a Global HIV Vaccine Enterprise. The authors invited discussion of this proposal, and challenged scientists to identify new strategies and mechanisms to accelerate the global effort to develop a safe and effective HIV vaccine. This paper describes the processes that led to agreement on the major roadblocks in HIV vaccine development, summarizes current scientific priorities, and describes an initial strategic approach to address those priorities.
Date: January 18, 2005
Title: A Shot in the Arm for AIDS Vaccine Research
Source: Public Library of Science (PLOS)
Summary: The scientific strategic plan of the Global HIV/AIDS Vaccine Enterprise, published in this month's PLoS Medicine, is a clear and cogent document describing how major funders and stakeholders in HIV vaccine development should move forward in a collaborative fashion. There is no doubt that this roadmap will be regarded as a useful instrument to bring greater cohesion and coordination to the field.
Date: December 28, 2004
Title: Israeli vaccine strengthens immunity
Source: News-Medical.Net
Summary: A research team at the Hadassah University Medical Center in Jerusalem has developed a vaccine that significantly strengthens the body’s immune system against the autoimmune sequela of HIV infection.
Date: December 26, 2004
Title: Doctor dispenses hope to HIV/AIDS patients in Haiti
Source: St. Petersburg Times
Summary: Dr. Jean W. Pape is a rare commodity in a country racked by gang violence and political intolerance. The Haitian doctor runs one of the oldest HIV/AIDS research institutes in the world.
Date: November 5, 2004
Title: Seattle tests an HIV vaccine
Source: UW Daily
Summary: A Seattle college student is motivated by humanitarian concerns to become a participant in an HIV vaccine study.
Date: July 16, 2004
Title: Ethical outreach for AIDS research
Source: Center News
Summary: One challenge of conducting vaccine trials is to ensure that study volunteers receive ethical protections mandated by U. S. federal research agencies. A new collaborative venture of HVTN staff and the center’s Institutional Review Office (IRO) promises to help countries with limited resources strengthen their ability to comply with these requirements.
Date: July 16, 2004
Title: 15th International AIDS Conference
Source: Kaiser Network
Summary: Daily coverage of the 15th International AIDS Conference held in Bangkok, Thailand.
Date: June 11, 2004
Title: United Nations welcomes G-8 backing
Source: United Nations News Centre
Summary: Two United Nations agencies welcomed the endorsement by the leaders of the Group of Eight most-industrialized countries of a new international consortium for accelerating the development of an HIV vaccine.
Date: March 31, 2004
Title: HIV Vaccine Trials in San Francisco Attract Cal Volunteers
Source: The Daily Californian
Summary: UC Berkeley students have joined the fight against the AIDS epidemic by participating in HIV vaccine clinical trials in San Francisco. The trials are being conducted by the San Francisco Department of Public Health, in conjunction with the HIV Vaccine Trials Network (HVTN) with the goal of speeding the delivery of an effective HIV vaccine.
Date: March 1, 2004
Title: Columbia University Researchers Advance Quest to Find HIV Vaccine
Source: Columbia Spectator
Summary: Researchers at the College of Physicians and Surgeons, along with scientists across the country working for the HIV Vaccine Trial Network, are in the process of creating vaccines to fight the virus that killed between 2.5 and 3.5 million people in 2003 alone.
Date: January 30, 2004
Title: Seattle Doctors Testing New HIV Vaccines
Source: Komo 4 News
Summary: The Fred Hutchinson Cancer Research Center starts new trials to find out how safe the vaccines are and how they affect your immune system.
Date: January 16, 2004
Title: Thailand rejects criticism of AIDS vaccine trial for 16,000
Source: USA Today
Summary: Thailand on Friday dismissed criticism by American HIV researchers that a massive test of a possible AIDS vaccine on thousands of healthy Thais would fail, saying the U.S.-funded trial still has hopes of breaking new ground.
Date: January 15, 2004
Title: India targets local HIV strain in test of AIDS vaccine
Source: Nature
Summary: India is gearing up to test an AIDS vaccine targeted at its most prevalent strain of HIV for the first time. Safety trials of the vaccine are expected to begin this summer.
Date: January 5, 2004
Title: HIV vaccine tested for Japanese patients
Source: Medical News Today
Summary: Doctors at the Research Hospital of Tokyo University's Institute of Medical Science have started clinical tests of an anti-HIV vaccine developed exclusively for the treatment of Japanese patients.
Date: November 13, 2003
Title: AIDSVAX has no impact in Thailand
Source: San Francisco Chronicle
Summary: AIDSVAX, VaxGen's experimental AIDS vaccine couldn't block HIV infection among volunteers in Thailand.
Date: June 27, 2003
Title: The Need for a Global Vaccine Enterprise
Source: Science Magazine
Summary: HVTN leaders join key figures in HIV vaccine research to propose a new, collaborative vision of global HIV vaccine development.
Date: June 27, 2003
Title: Gates Foundation panel calls for global blitz to find AIDS vaccine
Source: Seattle Post-Intelligencer
Summary: A world-class panel of scientists has proposed a massive, multibillion-dollar project to produce an AIDS vaccine.
Date: June 20, 2003
Title: Dedicated doctor to join AIDS vaccine trials
Source: The Star (South Africa)
Summary: For the first time in his life, Dr Reg Broekmann, the head of Soweto's Chris Hani Baragwanath hospital, has volunteered for a pharmaceutical trial. He is HIV-negative, which is a requirement for taking part in the trial.
Date: March 28, 2003
Title: In Hot Pursuit of HIV Vaccine
Source: Puget Sound Business Journal
Summary: This article notes HVTN's leadership role in facilitating the global effort to find an HIV vaccine, and describes the importance of the many other organizations and scientists in the Seattle area.
Date: September 1, 2002
Title: Will there be an AIDS vaccine anytime soon?
Source: Scientific American
Summary: It wasn't supposed to be this hard. When HIV, the virus responsible for AIDS, was first identified in 1984, Margaret M. Heckler, then secretary of the U.S. Department of Health and Human Services, predicted that a vaccine to protect against the scourge would be available within two years. Would that it had been so straightforward.
Date: July 16, 2002
Title: The Urgent Search for an AIDS Plan
Source: The New York Times
Summary: In theory, AIDS is preventable and treatable. But in reality, AIDS has spread so rapidly it rivals the worst epidemics in history.